High Tower Advisors, LLC Nephros Inc Transaction History
High Tower Advisors, LLC
- $68.3 Billion
- Q3 2024
A detailed history of High Tower Advisors, LLC transactions in Nephros Inc stock. As of the latest transaction made, High Tower Advisors, LLC holds 57,210 shares of NEPH stock, worth $84,670. This represents 0.0% of its overall portfolio holdings.
Number of Shares
57,210
Previous 57,210
-0.0%
Holding current value
$84,670
Previous $120,000
19.17%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding NEPH
# of Institutions
18Shares Held
4.28MCall Options Held
0Put Options Held
0-
Wexford Capital LP Greenwich, CT3.6MShares$5.33 Million1.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA202KShares$298,9510.0% of portfolio
-
Bard Associates Inc Chicago, IL172KShares$255,1090.11% of portfolio
-
Geode Capital Management, LLC Boston, MA85.2KShares$126,1680.0% of portfolio
-
Elkhorn Partners Limited Partnership Omaha, NE36.4KShares$53,9320.04% of portfolio
About NEPHROS INC
- Ticker NEPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 10,318,800
- Market Cap $15.3M
- Description
- Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water ...